Influence of clindamycin on fibronectin-staphylococcal interactions

J. E. Doran, J. P. Rissing

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

This report examines the effects of subinhibitory concentrations of clindamycin on fibronectin-staphylococcal interactions. Using in-vitro binding assays, exposure of staphylococci to subinhibitory concentrations of clindamycin results in a dose-dependent decrease in fibronectin's ability to bind to treated organisms. Concomitant with decreased fibronectin binding is a decreased ability for fibronectin to mediate the phagocytosis of treated organisms by human polymorphonuclear leukocytes. Serum-mediated phagocytosis of clindamycin-treated organisms remained effective despite the reduction in fibronectin binding capabilities. These results suggest that the clinical use of clindamycin has the potential to affect bacterial binding of fibronectin, thus modifying the adherence of organisms to host surfaces without adversely effecting their clearance by the reticuloendothelial system.

Original languageEnglish (US)
Pages (from-to)75-83
Number of pages9
JournalJournal of Antimicrobial Chemotherapy
Volume12
Issue numberSUPPL. C
StatePublished - Dec 1 1983

Fingerprint

Clindamycin
Fibronectins
Phagocytosis
Mononuclear Phagocyte System
Staphylococcus
Neutrophils
Serum

ASJC Scopus subject areas

  • Microbiology
  • Pharmacology

Cite this

Influence of clindamycin on fibronectin-staphylococcal interactions. / Doran, J. E.; Rissing, J. P.

In: Journal of Antimicrobial Chemotherapy, Vol. 12, No. SUPPL. C, 01.12.1983, p. 75-83.

Research output: Contribution to journalArticle

@article{29ddad09fcb746d09368ddede47ed78c,
title = "Influence of clindamycin on fibronectin-staphylococcal interactions",
abstract = "This report examines the effects of subinhibitory concentrations of clindamycin on fibronectin-staphylococcal interactions. Using in-vitro binding assays, exposure of staphylococci to subinhibitory concentrations of clindamycin results in a dose-dependent decrease in fibronectin's ability to bind to treated organisms. Concomitant with decreased fibronectin binding is a decreased ability for fibronectin to mediate the phagocytosis of treated organisms by human polymorphonuclear leukocytes. Serum-mediated phagocytosis of clindamycin-treated organisms remained effective despite the reduction in fibronectin binding capabilities. These results suggest that the clinical use of clindamycin has the potential to affect bacterial binding of fibronectin, thus modifying the adherence of organisms to host surfaces without adversely effecting their clearance by the reticuloendothelial system.",
author = "Doran, {J. E.} and Rissing, {J. P.}",
year = "1983",
month = "12",
day = "1",
language = "English (US)",
volume = "12",
pages = "75--83",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "SUPPL. C",

}

TY - JOUR

T1 - Influence of clindamycin on fibronectin-staphylococcal interactions

AU - Doran, J. E.

AU - Rissing, J. P.

PY - 1983/12/1

Y1 - 1983/12/1

N2 - This report examines the effects of subinhibitory concentrations of clindamycin on fibronectin-staphylococcal interactions. Using in-vitro binding assays, exposure of staphylococci to subinhibitory concentrations of clindamycin results in a dose-dependent decrease in fibronectin's ability to bind to treated organisms. Concomitant with decreased fibronectin binding is a decreased ability for fibronectin to mediate the phagocytosis of treated organisms by human polymorphonuclear leukocytes. Serum-mediated phagocytosis of clindamycin-treated organisms remained effective despite the reduction in fibronectin binding capabilities. These results suggest that the clinical use of clindamycin has the potential to affect bacterial binding of fibronectin, thus modifying the adherence of organisms to host surfaces without adversely effecting their clearance by the reticuloendothelial system.

AB - This report examines the effects of subinhibitory concentrations of clindamycin on fibronectin-staphylococcal interactions. Using in-vitro binding assays, exposure of staphylococci to subinhibitory concentrations of clindamycin results in a dose-dependent decrease in fibronectin's ability to bind to treated organisms. Concomitant with decreased fibronectin binding is a decreased ability for fibronectin to mediate the phagocytosis of treated organisms by human polymorphonuclear leukocytes. Serum-mediated phagocytosis of clindamycin-treated organisms remained effective despite the reduction in fibronectin binding capabilities. These results suggest that the clinical use of clindamycin has the potential to affect bacterial binding of fibronectin, thus modifying the adherence of organisms to host surfaces without adversely effecting their clearance by the reticuloendothelial system.

UR - http://www.scopus.com/inward/record.url?scp=0021031717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021031717&partnerID=8YFLogxK

M3 - Article

C2 - 6315672

AN - SCOPUS:0021031717

VL - 12

SP - 75

EP - 83

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - SUPPL. C

ER -